Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 54Gastrointestinal 42Thoracic 28Gynecologic 25Genitourinary 19Other hematologic neoplasm 18Other solid neoplasm 17Lymphoid 15Tumor-Agnostic 14Other 13Dermatologic 6Other neoplasm 5Head & Neck 5CNS 4Sarcoma 3Plasma cell 3Myeloid 1Endocrine 1

Conditions

Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Eating 5Standard of Care 4Radiofrequency Ablation 4Exercise 4Surgical Procedures, Operative 3Radiosurgery 3Endoscopic Mucosal Resection 3Adrenalectomy 3lutetium Lu 177 dotatate 2Yoga 2Saline Solution 2Robotic Surgical Procedures 2Resistance Training 2Proton Therapy 2Propofol 2Palliative Care 2Octreotide 2Magnetic Resonance Imaging 2Lutetium-177 2Liquid Biopsy 2Interviews as Topic 2Hydrocortisone 2Diet, Mediterranean 2Diet 2Desflurane 2Data Collection 2Conversion to Open Surgery 2Control Groups 2Calcium 23-Iodobenzylguanidine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Methods × Endocrine × Clear all
NCT04478175 2022-11-17

DParcoursDig

Institut Curie

Phase NA Completed
30 enrolled
Endocrine

Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡